Medtronic (NYSE: MDT) announced today that the FDA cleared its Hugo robotic-assisted surgery system for use in urologic surgical procedures.

Medtronic's Hugo surgical robot gained FDA clearance for urologic procedures, opening U.S. market entry and setting the stage ...

Dr. Nguyen Ba My Nhi, a Level II Specialist at HCMC’s Tam Anh General Hospital, gently presses the pedal and firmly grips the ...

Medtronic has announced that the U.S. Food and Drug Administration (FDA) has cleared the Hugo robotic-assisted surgery (RAS) ...

With the U.S. authorization for urologic procedures, “there is now choice” for hospitals that want to expand their robotic ...

With FDA clearance, the Hugo RAS system is indicated for use in minimally invasive urologic surgical procedures including prostatectomy, nephrectomy, and cystectomy — common procedures that account ...

The long-awaited FDA clearance sets up a showdown in the surgical robotics market between Medtronic and Intuitive Surgical.

Hologic’s HOLX GYN Surgical segment posted fourth-quarter revenues of $172.5 million, up 10.2% year over year. This marked the strongest growth in fiscal 2025, as the company had earlier anticipated, ...

Intuitive Surgical grapples with a GLP-1-driven bariatric slump but leans on strong general surgery gains and rising da Vinci ...

Hugo is heading to the U.S., with Medtronic finally securing a stateside clearance for its robotic surgery platform. | The ...

Writing for MedPage Today in opposition to the change, Dr. Anna Whelan, Dr. Erinma Ukoha and Dr. Hayley Miller argued that an ...